A bunch of analysts cut price targets on these 3 stocks this week. Here's why

  • 📰 CNBC
  • ⏱ Reading Time:
  • 43 sec. here
  • 10 min. at publisher
  • 📊 Quality Score:
  • News: 49%
  • Publisher: 72%

Adobe Inc. News

Remy Cointreau SA,Nice Ltd,Remy Cointreau SA

Despite the price target cuts, analysts still give one of the stocks over 60% potential upside.

Analysts have slashed price targets on three stocks from around the world over the past week: Adobe , France's Remy Cointreau , and Israeli software provider NICE . Remy Cointreau and NICE shares are also traded in the U.S.

Pro screened for global stocks that have had price target cuts from five or more analysts in the past seven days, and also have potential upside of over 25%. Adobe Five analysts cut their price targets ahead of Adobe's second-quarter earnings report, released after the bell Thursday. Analysts say investors are concerned about Adobe's competitive moat versus startups such as Canva and Figma.

which builds customer relationship management software, saw five analyst price target cuts over the past week. Investors are worried that the Israeli technology company, which also has a listing on Nasdaq, will face a disruption in its business due to the rise in artificial intelligence. In response, the company has said it is growing its AI and digital business, which makes up 8% of its cloud revenue with $150 million in annual revenues.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

XRP Skyrockets 60% in Volume as XRP Price Outperforms BitcoinXRP trading volume soared 60% in 24 hours, outperforming Bitcoin with significant price gains amid market decline and Coinbase listing
Source: Utoday_en - 🏆 295. / 63 Read more »

Goldman Sachs says buy this biotech stock with more than 60% upsideThe investment bank initiated coverage of the pharmaceuticals stock with a buy rating.
Source: CNBC - 🏆 12. / 72 Read more »

Goldman Sachs names global ‘alpha’ stock ideas — and gives one nearly 60% upsideGoldman Sachs' list of opportunities include stocks with 'deep value' and 'defensive growth' characteristics. Here are five of them.
Source: CNBC - 🏆 12. / 72 Read more »